Liver Disease Therapeutics Market By Treatment (Antiviral Drugs, Immunosuppressive Drugs, Corticosteroids, Liver Transplantation, Chemotherapy, Other. ), By Disease (Hepatitis B, Hepatitis C, Non-Alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Cirrhosis, Other), By Route of Administration (Oral, Injectable, Intravenous, Topical.), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales), and By End-user (Hospitals, Clinics, Homecare Settings, Research Institutions, Pharmaceutical, Other), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Nov 2024 | Report ID: MI1431 | 235 Pages
Report Coverage:
By Treatment
- Antiviral Drugs
- Immunosuppressive Drugs
- Corticosteroids
- Liver Transplantation
- Chemotherapy
- Other
By Disease Type
- Hepatitis B
- Hepatitis C
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Alcoholic Liver Disease (ALD)
- Liver Cirrhosis
- Other
By Route of Administration
- Oral
- Injectable
- Intravenous
- Topical
By Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Direct Sales
By End-user
- Hospitals
- Clinics
- Homecare Settings
- Research Institutions
- Pharmaceutical
- Other
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Gilead Sciences, Inc.
- AbbVie Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Novo Nordisk A/S
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- GlaxoSmithKline Plc (GSK)
- Hepatitis B Foundation
- Intercept Pharmaceuticals, Inc.
- Eli Lilly and Company
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Alexion Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc.
- Mylan N.V.
- Sanofi S.A.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.